NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cardiovascular Disease



Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in type 1 diabetes



September 27th, 2004

Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in an early stage of type 1 diabetes through activation of JNK.

"14-3-3 family members are dimeric, phosphoserine binding proteins that regulate signal transduction, apoptotic, and checkpoint control pathways. Recently, cardiomyocyte apoptosis has been characterized in type 1 diabetes mellitus. In order to study the molecular mechanism underlying diabetes-induced cardiomyocyte apoptosis, we examined the role of 14-3-3 protein and MAPK pathways in transgenic mice with cardiac specific expression of dominant negative 14-3-3eta (DN-14-3-3)," scientists writing in the journal Biochemical and Biophysical Research...


Source: Diabetes Week (2004-09-27)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login